Skip to content
Unrated Medical device recall · FDA · Published July 24, 2017

Platinium VR DF4 1240 ICD Recall: Risk of Overconsumption After ESD or MRI

Sorin Group recalls Platinium VR DF4 1240 ICDs with model TDF035U due to potential overconsumption after electrostatic discharge during surgery or MRI scans. Affected patients should contact manufacturer for guidance.

🇺🇸 FDA recall #Z-3231-2017Medical deviceSorin Group ›
Take action

Contact the company

Recalling firmSorin Group Italia SRL - CRFVia Crescentino · Saluggia, VC, Italy
✎ GovInfoNow plain-language explainer

What happened, in plain English

Sorin Group is recalling Platinium VR DF4 1240 implantable cardioverter defibrillators (ICDs) with model number TDF035U. The recall is due to a potential risk of overconsumption following electrostatic discharge during surgery or MRI scans. This could affect patients with specific heart conditions who require these devices. Read more at govinfonow.com/recall/73363-platinium-vr-df4-1240-icd-recall-risk-of-overconsumption-after.

Source Summary by GovInfoNow · govinfonow.com/recall/73363-platinium-vr-df4-1240-icd-recall-risk-of-overconsumption-after · Updated September 20, 2026 · FDA enforcement record: FDA #Z-3231-2017

Cite this page

“Platinium VR DF4 1240 ICD Recall: Risk of Overconsumption After ESD or MRI.” GovInfoNow, updated September 20, 2026. https://govinfonow.com/recall/73363-platinium-vr-df4-1240-icd-recall-risk-of-overconsumption-after. Based on FDA recall #Z-3231-2017 (https://api.fda.gov/device/enforcement.json?search=recall_number:%22Z-3231-2017%22&limit=1).

Why it’s dangerous

The device may overconsume during electrostatic discharge events that occur during implant surgery or MRI scans. This could lead to improper device function or failure in patients who rely on the device for life-saving cardiac monitoring.

Who’s affected

Patients with biventricular or ventricular antitachycardia pacing who require an implantable cardioverter defibrillator (ICD) for high-risk cardiac conditions. Those who have undergone surgery or MRI scans with the affected device are most at risk.

How to tell if you have this one

Check for the model number TDF035U on the device. The product was sold with serial numbers starting with 08031527015460. Affected devices are used for patients at high risk of sudden cardiac death due to ventricular tachyarrhythmias.

  • Brand
    Sorin Group
  • Product
    Platinium VR DF4 1240, Model Number TDF035U, UDI/GTIN 08031527015460, Implantable cardioverter defibrillator
  • Category
    Medical device
FDA recall event · 6 products

All 6 products in this recall

FDA lists each product line separately under one recall event. Check your product description, lot or code numbers against each row. Every row shares the hazard and remedy on this page.

  • Classification
    Class II
  • Status
    Terminated
  • Distribution
    US Nationwide Distribution
Recall numberProduct, codes & lotsQuantity
Z-3228-2017Platinium VR 1210, Model Number TDF031U, UDI/GTIN 08031527015514, Implantable cardioverter defibrillator, Biventricular or ventricular antitachycardia pacing, Dual or single chamber arrhythmia detection Product Usage: PLATINIUM VR is indicated for use in patients who are at high risk of sudden cardiac death due to ventricular tachyarrhythmias and who have experienced one of the following situations: - Survival of at least one episode of cardiac arrest (manifested by the loss of consciousness) due to ventricular tachyarrhythmia, - Recurrent, poorly tolerated sustained ventricular tachycardia (VT).; All Serial Numbers125 units
Z-3229-2017Platinium DR 1510, Model Number TDF032U, UDI/GTIN 08031527015521, Implantable cardioverter defibrillator, Biventricular or ventricular antitachycardia pacing, Dual or single chamber arrhythmia detection Product Usage: PLATINIUM VR is indicated for use in patients who are at high risk of sudden cardiac death due to ventricular tachyarrhythmias and who have experienced one of the following situations: - Survival of at least one episode of cardiac arrest (manifested by the loss of consciousness) due to ventricular tachyarrhythmia, - Recurrent, poorly tolerated sustained ventricular tachycardia (VT).; All Serial Numbers206 units
Z-3230-2017Platinium CRT DF1 1711, Model Number TDF033U, UDI/GTIN 08031527015538, Implantable cardioverter defibrillator, Biventricular or ventricular antitachycardia pacing, Dual or single chamber arrhythmia detection Product Usage: PLATINIUM VR is indicated for use in patients who are at high risk of sudden cardiac death due to ventricular tachyarrhythmias and who have experienced one of the following situations: - Survival of at least one episode of cardiac arrest (manifested by the loss of consciousness) due to ventricular tachyarrhythmia, - Recurrent, poorly tolerated sustained ventricular tachycardia (VT).; All Serial Numbers154 units
Z-3231-2017Platinium VR DF4 1240, Model Number TDF035U, UDI/GTIN 08031527015460, Implantable cardioverter defibrillator, Biventricular or ventricular antitachycardia pacing, Dual or single chamber arrhythmia detection Product Usage: PLATINIUM VR is indicated for use in patients who are at high risk of sudden cardiac death due to ventricular tachyarrhythmias and who have experienced one of the following situations: - Survival of at least one episode of cardiac arrest (manifested by the loss of consciousness) due to ventricular tachyarrhythmia, - Recurrent, poorly tolerated sustained ventricular tachycardia (VT).; All Serial Numbers72 units
Z-3232-2017Platinium DR DF4 1540, Model Number TDF036U, UDI/GTIN 08031527015477, Implantable cardioverter defibrillator, Biventricular or ventricular antitachycardia pacing, Dual or single chamber arrhythmia detection Product Usage: PLATINIUM VR is indicated for use in patients who are at high risk of sudden cardiac death due to ventricular tachyarrhythmias and who have experienced one of the following situations: - Survival of at least one episode of cardiac arrest (manifested by the loss of consciousness) due to ventricular tachyarrhythmia, - Recurrent, poorly tolerated sustained ventricular tachycardia (VT).; All Serial Numbers86 units
Z-3233-2017Platinium CRT-D 1741, Model Number TDF037U, UDI/GTIN 08031527015484, Implantable cardioverter defibrillator, Biventricular or ventricular antitachycardia pacing, Dual or single chamber arrhythmia detection Product Usage: PLATINIUM VR is indicated for use in patients who are at high risk of sudden cardiac death due to ventricular tachyarrhythmias and who have experienced one of the following situations: - Survival of at least one episode of cardiac arrest (manifested by the loss of consciousness) due to ventricular tachyarrhythmia, - Recurrent, poorly tolerated sustained ventricular tachycardia (VT).; All Serial Numbers68 units
Based on the official FDA remedy

What to do — step by step

  1. Contact Manufacturer

    Reach out to Sorin Group for specific guidance on device safety and next steps.

Where it went and when

Where it was distributed

Distributed nationwide.

Alaska: yesAKMaine: yesMEVermont: yesVTNew Hampshire: yesNHWashington: yesWAIdaho: yesIDMontana: yesMTNorth Dakota: yesNDMinnesota: yesMNIllinois: yesILWisconsin: yesWIMichigan: yesMINew York: yesNYRhode Island: yesRIMassachusetts: yesMAOregon: yesORNevada: yesNVWyoming: yesWYSouth Dakota: yesSDIowa: yesIAIndiana: yesINOhio: yesOHPennsylvania: yesPANew Jersey: yesNJConnecticut: yesCTCalifornia: yesCAUtah: yesUTColorado: yesCONebraska: yesNEMissouri: yesMOKentucky: yesKYWest Virginia: yesWVVirginia: yesVAMaryland: yesMDDelaware: yesDEArizona: yesAZNew Mexico: yesNMKansas: yesKSArkansas: yesARTennessee: yesTNNorth Carolina: yesNCSouth Carolina: yesSCDistrict of Columbia: yesDCOklahoma: yesOKLouisiana: yesLAMississippi: yesMSAlabama: yesALGeorgia: yesGAHawaii: yesHITexas: yesTXFlorida: yesFL

FDA distribution: “US Nationwide Distribution” States read from FDA’s own wording; “not listed” means the notice does not name it.

Distributed nationwide.

Recall timeline

FDA terminated this recall 6.5 years after the firm started it.

1. Firm started the recall: Jul 24, 201712. FDA classified it Class II: Sep 27, 201723. Published in FDA’s Enforcement Report: Oct 4, 201734. FDA terminated the recall: Jan 29, 2024420172024
  1. Firm started the recall
  2. FDA classified it Class II
  3. Published in FDA’s Enforcement Report
  4. FDA terminated the recall

Dates from the agency record only; steps without a date are left out.

Similar recalls

Latest medical device recalls

Keep exploring

Where this comes from

The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.

  • Official source: FDA Recall #Z-3231-2017 (July 24, 2017) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for Z-3231-2017 to see it in context.
  • Plain-language summary written by qwen3:4b on September 20, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
  • GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.
GovInfoNow is an independent guide. We are not FDA or any government agency. Always confirm details with the official recall.Data: CPSC · FDA · NHTSA · USDA